Bao'an, China: plans to transfer 79.8144% of its equity in Beijing Mayinglong Changqing Hospital Management Co., Ltd. to Zhuo Zhun Technology.

Sina Finance news on March 30th, China Baoan announced that its subsidiary Ma Yinglong Pharmaceutical Group Co., Ltd. has signed a "Equity Transfer Agreement" with Zhuo Zhun Technology Co., Ltd., a controlling subsidiary of Ma Yinglong Healthcare Management Co., Ltd., in order to optimize the medical industry structure. It is planned to transfer 79.8144% equity of Beijing Ma Yinglong Changqing Hospital Management Co., Ltd. held by them to Zhuo Zhun Technology at a transaction price of 104 million yuan. If this transaction is completed, Beijing Medical Management and its controlling subsidiary Beijing Ma Yinglong Changqing Proctology Hospital Co., Ltd. will no longer be included in the company's consolidated financial statements.